Chemotherapy is administrated intravenously and is majorly conducted in hospital. It involves administration of medicine through a tube in a vein. Intravenous medications are given directly into the blood stream through a variety of methods. A venous access device (VAD) is a surgically implanted device that provides long-term access to a major vein. The two most commonly used VAD for cancer treatment are catheter and implanted ports. Intravenous (IV) administration of therapy medication allows for rapid entry into the body's circulation, where it is carried throughout the body in the blood stream. IV methods also enable more flexibility with drug dosing.
Market Dynamics
Increasing incidences of different cancers worldwide is the major factor driving chemotherapy devices market growth. According to the World Health Organization (WHO), 2017, nearly 1 in 6 deaths occur due to cancer globally and around 70% of deaths from cancer occur in low- and middle-income economies. According to Breast Cancer Organization, in 2017, approximately 252,710 new cases of breast cancer were identified in the U.S., of which 63,410 cases were of non-invasive breast cancer.
Moreover, increasing government and private funding coupled with rising disposable income is also projected to drive chemotherapy devices market growth. According to the National Cancer Institute 2016 report, an estimated national expenditures for cancer care in the U.S. in 2017, were US$ 147.3 billion. Costs are likely to increase over the forecast period, as the population ages and cancer prevalence increases. However, not all chemotherapy patient requires a venous access device. For some chemotherapy treatment plans, the inconvenience of implanting and accessing a VAD can outweigh the benefits.
Key features of the study:
- This report provides in-depth analysis of the chemotherapy devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global chemotherapy devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Advanced Chemotherapy Technologies, Baxter International, Becton, Dickinson Company, B. Braun, Fresenius Kabi, Halyard Health, ICU Medical, Moog Inc., Micrel Medical, Smiths Group, Terumo Corporation, and Zyno Medical
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global chemotherapy devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for chemotherapy devices market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Chemotherapy Devices Market, By Product:
- Catheter
- Non-tunnelled catheters
- Tunnelled central catheters
- Surgically implantable catheters or ports
- Peripherally inserted central catheters (PICC)
- Cannula
- Global Chemotherapy Devices Market, By End User:
- Hospital
- Clinics
- Home Care
- Global Chemotherapy Devices Market, By Region:
- North America
- By Country:
- By Product:
- Catheter
- Non-tunnelled catheters
- Tunnelled central catheters
- Surgically implantable catheters or ports
- Peripherally inserted central catheters (PICC)
- Cannula
- By End Use:
- Hospital
- Clinics
- Home Care
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Product:
- Catheter
- Non-tunnelled catheters
- Tunnelled central catheters
- Surgically implantable catheters or ports
- Peripherally inserted central catheters (PICC)
- Cannula
- By End Use:
- Hospital
- Clinics
- Home Care
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Product:
- Catheter
- Non-tunnelled catheters
- Tunnelled central catheters
- Surgically implantable catheters or ports
- Peripherally inserted central catheters (PICC)
- Cannula
- By End Use:
- Hospital
- Clinics
- Home Care
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product:
- Catheter
- Non-tunnelled catheters
- Tunnelled central catheters
- Surgically implantable catheters or ports
- Peripherally inserted central catheters (PICC)
- Cannula
- By End Use:
- Hospital
- Clinics
- Home Care
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product:
- Catheter
- Non-tunnelled catheters
- Tunnelled central catheters
- Surgically implantable catheters or ports
- Peripherally inserted central catheters (PICC)
- Cannula
- By End Use:
- Hospital
- Clinics
- Home Care
- Africa
- By Country:
- South Africa
- Central Africa
- North Africa
- By Product:
- Catheter
- Non-tunnelled catheters
- Tunnelled central catheters
- Surgically implantable catheters or ports
- Peripherally inserted central catheters (PICC)
- Cannula
- By End Use:
- Hospital
- Clinics
- Home Care
- Company Profiles
- Advanced Chemotherapy Technologies*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Baxter International
- Becton, Dickinson Company
- Braun
- Fresenius Kabi
- Halyard Health
- ICU Medical
- Moog Inc.
- Micrel Medical
- Smiths Group
- Terumo Corporation
- Zyno Medical
“*” marked represents similar segmentation in other categories in the respective section.
